Display options
Cite
Ajani EO, Shallie PD, Adegbesan BO, et al. Protective effect of Garcinia kola (kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate. Afr J Tradit Complement Altern Med. 2008;5(2):180-6doi: 10.4314/ajtcam.v5i2.31271.
Ajani, E. O., Shallie, P. D., Adegbesan, B. O., Salau, B. A., & Adesanya, M. (2008). Protective effect of Garcinia kola (kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate. African journal of traditional, complementary, and alternative medicines : AJTCAM, 5(2), 180-6. https://doi.org/10.4314/ajtcam.v5i2.31271
Ajani, E O, et al. "Protective effect of Garcinia kola (kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate." African journal of traditional, complementary, and alternative medicines : AJTCAM vol. 5,2 (2008): 180-6. doi: https://doi.org/10.4314/ajtcam.v5i2.31271
Ajani EO, Shallie PD, Adegbesan BO, Salau BA, Adesanya M. Protective effect of Garcinia kola (kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate. Afr J Tradit Complement Altern Med. 2008 Jan 22;5(2):180-6. doi: 10.4314/ajtcam.v5i2.31271. PMID: 20161935; PMCID: PMC2816536.
Copy Download .nbib Format: NLM
Share it on

Afr J Tradit Complement Altern Med. 2008 Jan 22;5(2):180-6. doi: 10.4314/ajtcam.v5i2.31271.

Protective effect of Garcinia kola (kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate.

African journal of traditional, complementary, and alternative medicines : AJTCAM

E O Ajani, P D Shallie, B O Adegbesan, B A Salau, M Adesanya

Affiliations

  1. Department of Biochemistry, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Remo Campus, Ikenne.

PMID: 20161935 PMCID: PMC2816536 DOI: 10.4314/ajtcam.v5i2.31271

Abstract

This study was carried out to investigate the cardiovascular effect of administration of antimalarial drugs amodiaquine and artesunate and the efficacy of Garcinia kola extract (kolaviron) in protecting against such possible effect. Thirty (30) adult male albino rats divided into six (6) groups were used in this study. Groups D, E and F were treated with 100 mg/Kg b. w. of the extract twice daily for the first one week and 200 mg/Kg b. w./day for the subsequent three (3) weeks. Amodiaquine (10 mg/Kg b. w./day) was administered orally for four (4) days into rats in groups A and E while rats in groups B and F were treated with artesunate (5 mg/Kg b. w./day) for four (4) days. Group C rats (normal control) were treated with normal saline. All the rats were sacrificed after four (4) weeks treatment period. Blood was withdrawn by cardiac puncture while the liver, kidney, stomach and heart were removed, cleansed and weighed. Total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides were measured in the serum, while total fibrinogen, platelet count, red blood cell and white blood cell count were measured in the whole blood. The artherogenic and coronary risk index were also determined. Results indicate that both amodiaquine and artesunate predispose to cardiovascular disease, however the effect was more pronounced with artesunate than amodiaquine. The result also suggests that both drugs could increase the risk of coronary and artherogenic diseases and that Garcinia kola do not prevent the cardiotoxicity and coronary risk effect.

Keywords: Cardiovascular disease risk factor; Garcinia kola; amodiaquine and artesunate

References

  1. Lancet. 2004 Jan 3;363(9402):9-17 - PubMed
  2. Arteriosclerosis. 1988 May-Jun;8(3):207-11 - PubMed
  3. Pharmacol Res. 2000 Jul;42(1):75-80 - PubMed
  4. Am J Epidemiol. 1996 Apr 1;143(7):665-76 - PubMed
  5. J Nutr. 1998 Nov;128(11):1927-32 - PubMed
  6. World Health Organ Tech Rep Ser. 1990;805:1-141 - PubMed
  7. BMJ. 1991 Sep 14;303(6803):596-7 - PubMed
  8. Clin Exp Pharmacol Physiol. 2005 Jan-Feb;32(1-2):40-6 - PubMed
  9. Ophthalmic Epidemiol. 1999 Dec;6(4):279-90 - PubMed
  10. J Pharm Pharmacol. 1990 Apr;42(4):290-2 - PubMed
  11. J Am Coll Nutr. 2003 Feb;22(1):71-9 - PubMed
  12. Am J Epidemiol. 1987 Dec;126(6):1093-102 - PubMed
  13. Lancet. 1984 Feb 18;1(8373):357-9 - PubMed
  14. Eur J Cancer Prev. 2000 Oct;9(5):351-61 - PubMed

Publication Types